Objective
This study’s goal is to determine whether an anti-inflammatory drug (colchicine) and an antiplatelet drug (aspirin), in combination or alone, can prevent cardiovascular events in patients with type 2 diabetes who have no known history of cardiovascular disease.
Involvement
Take the studied medication daily. The medication will be delivered to your home every six months. Follow-ups will be done by phone or video chat, with no hospital visit required.
Duration
Between 36 and 54 months.
Eligibility criteria
- Having type 2 diabetes
- Being between 55 and 80 years of age
- Have no known history of cardiovascular disease
For more information about the study or to participate:
- Read the full announcement
- Visit the website: https://colcot-t2d.org/en
- Call 1-877-587-3389